Bioqual, Inc. (BIOQ)
OTCMKTS · Delayed Price · Currency is USD
37.51
-0.19 (-0.50%)
At close: Feb 6, 2026

Bioqual Income Statement

Millions USD. Fiscal year is Jun - May.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '25 May '25 May '24 May '23 May '22 May '21
46.5448.8758.5962.6666.1557.68
Revenue Growth (YoY)
-7.50%-16.59%-6.50%-5.27%14.68%24.43%
Cost of Revenue
35.8439.7346.5550.0649.239.82
Gross Profit
10.79.1412.0512.616.9517.86
Selling, General & Admin
10.5711.0312.0611.510.429.31
Operating Expenses
10.5711.0312.0611.510.429.31
Operating Income
0.13-1.9-0.021.16.538.56
Interest & Investment Income
0.570.610.480.0300
Other Non Operating Income (Expenses)
0.0900.0200.040.06
EBT Excluding Unusual Items
0.78-1.290.481.136.588.62
Pretax Income
0.78-1.290.481.136.588.62
Income Tax Expense
0.33-0.24-0.010.31.322.29
Net Income
0.45-1.050.480.845.266.33
Net Income to Common
0.45-1.050.480.845.266.33
Net Income Growth
---42.14%-84.12%-16.85%49.54%
Shares Outstanding (Basic)
111111
Shares Outstanding (Diluted)
111111
Shares Change (YoY)
----0.00%0.04%0.01%
EPS (Basic)
0.51-1.170.540.935.887.08
EPS (Diluted)
0.51-1.170.540.935.887.08
EPS Growth
---41.94%-84.18%-16.91%49.61%
Free Cash Flow
52.718.765.99-4.57-2.26
Free Cash Flow Per Share
5.583.039.806.69-5.11-2.53
Dividend Per Share
0.5000.5000.5000.5001.0001.250
Dividend Growth
----50.00%-20.00%13.64%
Gross Margin
22.98%18.70%20.56%20.11%25.62%30.97%
Operating Margin
0.27%-3.88%-0.03%1.76%9.88%14.83%
Profit Margin
0.97%-2.15%0.83%1.33%7.95%10.97%
Free Cash Flow Margin
10.73%5.54%14.95%9.55%-6.91%-3.92%
EBITDA
2.420.472.543.388.259.92
EBITDA Margin
5.20%0.97%4.33%5.39%12.46%17.19%
D&A For EBITDA
2.292.372.562.281.711.36
EBIT
0.13-1.9-0.021.16.538.56
EBIT Margin
0.27%-3.88%-0.03%1.76%9.88%14.83%
Effective Tax Rate
42.24%--26.27%20.01%26.57%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.